ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the Euro... (on ViroPharma and our business. For...)

ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union

Date:6/24/2011

on ViroPharma and our business.

Forward Looking Statements

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events, including our regulatory filings in Europe related to Buccolam, including without limitation statements related to potential regulatory timelines, the likelihood of regulatory success and the scope of indications for which Buccolam may be approved. The EC may view the data regarding the use of Buccolam for treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to less than 18 years) submitted in the PUMA as insufficient or inconclusive, request additional data, require additional clinical studies, delay any decision past the time frames anticipated by us, limit any approved indications, deny the approval of Buccolam. These factors, and other factors, including, but not limited to those described in our annual report on Form 10-K for the year ended December 31, 2010 and 10-Q for the quarter ended March 31, 2011 filed with the Securities and Exchange Commission, could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release are made as of the date hereof and may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-looking statements. These forward looking statements should not be relied upon as representing our assessments as of any date subsequent to the date of this press release.

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
2. ViroPharma to Participate in the Jefferies 2011 Global Healthcare Conference
3. ViroPharma Launches Swell, an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema
4. ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
5. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
6. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
7. ViroPharma to Participate In Three May Healthcare Investor Conferences
8. ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011
9. ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR)
10. ViroPharma Launches HAE and Me, A New Online Community to Unite People Living With Hereditary Angioedema
11. ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union

Post Your Comments:

(Date:5/22/2013)... May 22, 2013 Ranbaxy Laboratories Limited ... Ltd. (hereafter, Daiichi Sankyo), announced on May 22 ... years to address past conduct under prior management ... Daiichi Sankyo continues to support Ranbaxy in ... of the past which led to the investigations ...

(Date:5/22/2013)... Israel , May 22, 2013 Rosetta Genomics ... and provider of microRNA-based molecular diagnostics, announces that ... Executive Officer of Rosetta Genomics, will deliver a corporate ... from June 3-6, 2013 in New York City. Mr. ... th at 2:00 p.m. Eastern time. ...

(Date:5/22/2013)... 22, 2013 BD (Becton, Dickinson and Company) (NYSE: ... company, announced today the publication of its 2012 ... and it continues to focus on the Company,s shared ... the principles of shared value — creating value for ... societies — are fundamental to our strategy," said ...

Breaking Medicine Technology:Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2 Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3 BD Issues 2012 Sustainability Report 2 BD Issues 2012 Sustainability Report 3

[0] Ranbaxy Announces Improved Business Standards and Quality Assurance Initiatives [0] Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference [0] BD Issues 2012 Sustainability Report

... Amgen and Pfizer today announced the launch of ... an online resource, providing a wealth of style advice ... mentor to the designers on TV,s "Project Runway" and ... Susan C. Taylor, M.D., the style guide includes five ...

... years of dedication to developing new, innovative treatments to help ... of people worldwide and can cause severe loss of vision, ... of the highest honors a physician can achieve. On Thursday ... Stein Living Tribute Award at the 2010 Vision Awards. ...

Cached Medicine Technology:Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn 2 Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn 3 Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn 4 Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn 5 Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn 6 Dr. Brian Boxer Wachler to be Honored With Olympic Gold Medal Bobsled Champion Steve Holcomb Alongside Apple CEO Steve Jobs, James Cameron, Dan Rather, Quincy Jones and Others at 2010 Vision Awards in Beverly Hills 2

Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn Dr. Brian Boxer Wachler to be Honored With Olympic Gold Medal Bobsled Champion Steve Holcomb Alongside Apple CEO Steve Jobs, James Cameron, Dan Rather, Quincy Jones and Others at 2010 Vision Awards in Beverly Hills

(Date:5/22/2013)... there is a gender gap when it comes to ... that does not appear to exist in children in ... levels of self-regulation than boys. Self-regulation is defined as ... directions, and persist on a task. It has been ... studies by Oregon State University researchers. , In ...

(Date:5/22/2013)... People in the United States have been taking ... In much of the world, water shortages are normal and ... She warns against taking water for granted and provides ways ... easily in the United States. , Sharon Kleyne is host ... heard live or by podcast on World Talk Radio, Voice ...

(Date:5/22/2013)... 22, 2013 DePuy Pinnacle lawsuit ... Pinnacle Hip Replacement System continue to move forward in ... Liebhard LLP reports. According to an Order dated ... produce monitoring reports associated with a 2007 criminal investigation ... marketing practices. Plaintiffs maintained in their December ...

(Date:5/22/2013)... Diversity Focus and Handicap This Productions announce ... promotes awareness that physical disabilities do not stop people ... be held Friday, June 14th at 7:30 p.m. at ... Handicap This! can be purchased at http://www.diversityfocus.org . ... to which their mind is handicap accessible. Mike ...

(Date:5/22/2013)... Twenty student-led startup companies at Arizona ... an intensive startup accelerator designed to help them execute ... create local jobs as part of ASU’s Edson ... initiative offers approximately 20 student teams up to $20,000 ... to launch their for-profit, more-than-profit or nonprofit ventures. The ...

[0] 'Boys will be boys' in US, but not in Asia [0] Water Advocate Sharon Kleyne Announces Water Conservation Appreciation [0] DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation [0] Handicap This! Comes to Marion, Iowa [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort

... led University of Southern California (USC) researchers to ... of an immune response protein (interleukin-12)., "We found ... in fighting intracellular infections, increases susceptibility to young ... associate professor of preventive medicine at the Keck ...

... BOTHELL, Wash., April 1, 2008 Verathon(R), ... offer improvement,in patient care, is expanding their ... their commitment to provide,innovative and practical infection ... http://www.newscom.com/cgi-bin/prnh/20061011/SFW044LOGO ), Urinary catheter-related UTIs ...

... this May to the Mental,Health Connection Challenge, ... 2008 May is Mental Health Month, Mental Health ... networks throughout May,to protect and improve their mental ... Mental Health Connection Challenge by,making FIVE positive and ...

... expands support to another ... leading pharmaceutical company, SOUTHFIELD, Mich., ... a worldwide provider of information technology,(IT), enterprise support and business ... has been selected by,sanofi-aventis recherche & developpement (research & development) ...

... Today, America,s,Health Insurance Plans (AHIP) joined ... and quality groups in supporting a,standard set ... and,reporting. These principles, which lay out best ... governments with performance measurement,and reporting systems, are ...

... health center-trained family physicians were more likely to work ... (64 percent versus 37 percent), based on a study ... news comes on the heels of last months announcement ... an increased interest in family medicine and more residency ...

Cached Medicine News:Health News:USC researchers find new clues to risk of Hodgkin lymphoma 2 Health News:Verathon(R) Offers Enhanced BladderScan(R) Instrument as Part of Continued Program to Eliminate Unnecessary Catheterizations, Decrease Urinary Tract Infections and Assist in Hospital Infection Control 2 Health News:Verathon(R) Offers Enhanced BladderScan(R) Instrument as Part of Continued Program to Eliminate Unnecessary Catheterizations, Decrease Urinary Tract Infections and Assist in Hospital Infection Control 3 Health News:'Get Connected' in May and Boost Your Mental Health 2 Health News:TechTeam Global Will Provide Multilingual EDC Support Services for sanofi-aventis recherche & developpement 2 Health News:TechTeam Global Will Provide Multilingual EDC Support Services for sanofi-aventis recherche & developpement 3 Health News:AHIP Endorses 'Patient Charter' to Guide Physician Performance Measurement, Reporting 2 Health News:Want docs to treat the underserved? Make sure they train at community health centers 2

USC researchers find new clues to risk of Hodgkin lymphoma Verathon(R) Offers Enhanced BladderScan(R) Instrument as Part of Continued Program to Eliminate Unnecessary Catheterizations, Decrease Urinary Tract Infections and Assist in Hospital Infection Control 'Get Connected' in May and Boost Your Mental Health TechTeam Global Will Provide Multilingual EDC Support Services for sanofi-aventis recherche & developpement AHIP Endorses 'Patient Charter' to Guide Physician Performance Measurement, Reporting Want docs to treat the underserved? Make sure they train at community health centers

... All Infectious Disease ELISA ... well format. Also included ... positive and negative controls, ... stop solution. Use an ...

... polymerase chain reaction (PCR) technology, the worlds ... essential component of Roches blood screening assays ... amounts of selected unique regions of genetic ... copies (that is, to detectable levels) in ...

... in New Technology, the Arrow International AutoCAT ... first and only IABP system that uses ... based timing algorithm, WAVE, to deliver beat ... Second generation Automaticity provides for sophisticated hands-off ...

... IHC, the worlds first truly ... system introduced a whole new ... combining system modularity and ease ... productivity. The NexES Systems automated ...

Medicine Products:

Chagas 96 wells TaqScreen West Nile Virus Test AutoCAT 2 WAVE Series Intra-Aortic Balloon Pump NexES® IHC